These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29072452)

  • 1. Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model.
    Fales KR; Njoroge FG; Brooks HB; Thibodeaux S; Torrado A; Si C; Toth JL; Mc Cowan JR; Roth KD; Thrasher KJ; Frimpong K; Lee MR; Dally RD; Shepherd TA; Durham TB; Margolis BJ; Wu Z; Wang Y; Atwell S; Wang J; Hui YH; Meier TI; Konicek SA; Geeganage S
    J Med Chem; 2017 Dec; 60(23):9599-9616. PubMed ID: 29072452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 6-substituted thieno[2,3-d]pyrimidine analogs as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis in folate receptor expressing human tumors.
    Wallace-Povirk A; Tong N; Wong-Roushar J; O'Connor C; Zhou X; Hou Z; Bao X; Garcia GE; Li J; Kim S; Dann CE; Matherly LH; Gangjee A
    Bioorg Med Chem; 2021 May; 37():116093. PubMed ID: 33773393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 5-substituted pyrrolo[2,3-d]pyrimidine antifolates as dual-acting inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis: implications of inhibiting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase to ampk activation and antitumor activity.
    Mitchell-Ryan S; Wang Y; Raghavan S; Ravindra MP; Hales E; Orr S; Cherian C; Hou Z; Matherly LH; Gangjee A
    J Med Chem; 2013 Dec; 56(24):10016-10032. PubMed ID: 24256410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of amide-bridged pyrrolo[2,3-d]pyrimidines as tumor targeted classical antifolates with selective uptake by folate receptor α and inhibition of de novo purine nucleotide biosynthesis.
    Xiang W; Dekhne A; Doshi A; O'Connor C; Hou Z; Matherly LH; Gangjee A
    Bioorg Med Chem; 2019 Dec; 27(23):115125. PubMed ID: 31679978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidines as potential nonclassical antifolates targeting both thymidylate and purine nucleotide biosynthesis.
    Liu Y; Zhang C; Zhang H; Li M; Yuan J; Zhang Y; Zhou J; Guo H; Zhao L; Du Y; Wang L; Ren L
    Eur J Med Chem; 2015 Mar; 93():142-55. PubMed ID: 25668494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
    Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
    Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine models.
    Brooks HB; Meier TI; Geeganage S; Fales KR; Thrasher KJ; Konicek SA; Spencer CD; Thibodeaux S; Foreman RT; Hui YH; Roth KD; Qian YW; Wang T; Luo S; Torrado A; Si C; Toth JL; Mc Cowan JR; Frimpong K; Lee MR; Dally RD; Shepherd TA; Durham TB; Wang Y; Wu Z; Iversen PW; Njoroge FG
    Sci Rep; 2018 Oct; 8(1):15458. PubMed ID: 30337562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 5-substituted pyrrolo[2,3-d]pyrimidines as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase and as potential antitumor agents.
    Wang Y; Mitchell-Ryan S; Raghavan S; George C; Orr S; Hou Z; Matherly LH; Gangjee A
    J Med Chem; 2015 Feb; 58(3):1479-93. PubMed ID: 25602637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes.
    Shih C; Chen VJ; Gossett LS; Gates SB; MacKellar WC; Habeck LL; Shackelford KA; Mendelsohn LG; Soose DJ; Patel VF; Andis SL; Bewley JR; Rayl EA; Moroson BA; Beardsley GP; Kohler W; Ratnam M; Schultz RM
    Cancer Res; 1997 Mar; 57(6):1116-23. PubMed ID: 9067281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of a novel series of 6-substituted thieno[2,3-d]pyrimidine antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors over the reduced folate carrier and proton-coupled folate transporter for cellular entry.
    Deng Y; Zhou X; Kugel Desmoulin S; Wu J; Cherian C; Hou Z; Matherly LH; Gangjee A
    J Med Chem; 2009 May; 52(9):2940-51. PubMed ID: 19371039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 6-substituted benzoyl and non-benzoyl straight chain pyrrolo[2,3-d]pyrimidines as potential antitumor agents with multitargeted inhibition of TS, GARFTase and AICARFTase.
    Xing R; Zhang H; Yuan J; Zhang K; Li L; Guo H; Zhao L; Zhang C; Li S; Gao T; Liu Y; Wang L
    Eur J Med Chem; 2017 Oct; 139():531-541. PubMed ID: 28830032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and Enzymatic Analysis of Tumor-Targeted Antifolates That Inhibit Glycinamide Ribonucleotide Formyltransferase.
    Deis SM; Doshi A; Hou Z; Matherly LH; Gangjee A; Dann CE
    Biochemistry; 2016 Aug; 55(32):4574-82. PubMed ID: 27439469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of 6-substituted pyrrolo[2,3-d]pyrimidines as dual inhibitors of TS and AICARFTase and as potential antitumor agents.
    Liu Y; Li M; Zhang H; Yuan J; Zhang C; Zhang K; Guo H; Zhao L; Du Y; Wang L; Ren L
    Eur J Med Chem; 2016 Jun; 115():245-56. PubMed ID: 27017552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery, Synthesis, and Evaluation of Highly Selective Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) Inhibitor for the Potential Treatment of Metastatic Triple-Negative Breast Cancer.
    Li Y; Yang G; Zhang J; Tang P; Yang C; Wang G; Chen J; Liu J; Zhang L; Ouyang L
    J Med Chem; 2021 Aug; 64(16):12022-12048. PubMed ID: 34351741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Targeted Antifolates for Folate Receptor α and the Proton-Coupled Folate Transporter in Human Tumors.
    Wang L; Wallace A; Raghavan S; Deis SM; Wilson MR; Yang S; Polin L; White K; Kushner J; Orr S; George C; O'Connor C; Hou Z; Mitchell-Ryan S; Dann CE; Matherly LH; Gangjee A
    J Med Chem; 2015 Sep; 58(17):6938-59. PubMed ID: 26317331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced folate carrier and folylpolyglutamate synthetase, but not thymidylate synthase predict survival in pemetrexed-treated patients suffering from malignant pleural mesothelioma.
    Mairinger F; Vollbrecht C; Halbwedl I; Hatz M; Stacher E; Gülly C; Quehenberger F; Stephan-Falkenau S; Kollmeier J; Roth A; Mairinger T; Popper H
    J Thorac Oncol; 2013 May; 8(5):644-53. PubMed ID: 23449276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KR-33028, a potent inhibitor of the Na
    Amith SR; Wilkinson JM; Fliegel L
    Biochem Pharmacol; 2016 Oct; 118():31-39. PubMed ID: 27521504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting tumour proliferation with a small-molecule inhibitor of AICAR transformylase homodimerization.
    Spurr IB; Birts CN; Cuda F; Benkovic SJ; Blaydes JP; Tavassoli A
    Chembiochem; 2012 Jul; 13(11):1628-34. PubMed ID: 22764122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel class of monoglutamated antifolates exhibits tight-binding inhibition of human glycinamide ribonucleotide formyltransferase and potent activity against solid tumors.
    Habeck LL; Leitner TA; Shackelford KA; Gossett LS; Schultz RM; Andis SL; Shih C; Grindey GB; Mendelsohn LG
    Cancer Res; 1994 Feb; 54(4):1021-6. PubMed ID: 8313357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter.
    Cherian C; Kugel Desmoulin S; Wang L; Polin L; White K; Kushner J; Stout M; Hou Z; Gangjee A; Matherly LH
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):999-1011. PubMed ID: 23412628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.